Biller, B. M., Newell-Price, J., Fleseriu, M., Bertagna, X., Findling, J., Shimatsu, A., . . . Pivonello, R. (2019). OR16-2 Osilodrostat Treatment in Cushing's Disease (CD): Results from a Phase III, Multicenter, Double-Blind, Randomized Withdrawal Study (LINC 3). J Endocr Soc.
Παραπομπή Chicago StyleBiller, Beverly MK, et al. "OR16-2 Osilodrostat Treatment in Cushing's Disease (CD): Results From a Phase III, Multicenter, Double-Blind, Randomized Withdrawal Study (LINC 3)." J Endocr Soc 2019.
Παραπομπή MLABiller, Beverly MK, et al. "OR16-2 Osilodrostat Treatment in Cushing's Disease (CD): Results From a Phase III, Multicenter, Double-Blind, Randomized Withdrawal Study (LINC 3)." J Endocr Soc 2019.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.